Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Female subjects of non-childbearing potential and male subjects between the ages of 40 and 80 years, inclusive
Subjects with a diagnosis, for at least 6 months, of moderate to severe COPD and who meet the criteria for Stage II-III disease
Subjects must have a smoking history of at least 10 pack-years
You may not be if
Current evidence or history within the previous 6 months of any clinically significant disease (other than COPD) or abnormality in the opinion of the Investigator that would put the subject at risk or which would compromise the quality of the study data
A COPD exacerbation requiring treatment with oral steroids or hospitalization for the treatment of COPD within 3 months of Screening
Clareo Health | An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary Disease
